The inhibitors of PHGDH reduce the production of glucose-derived serine and suppress the growth of PHGDH-dependent breast cancers in culture and in orthotopic xenograft tumors and concomitantly reduce the nucleotide synthesis [22, 23]. Here, PHGDH is linked to breast cancer.